日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ppAT drives glutamine-dependent purine biosynthesis and malignant progression in hepatocellular carcinoma.

ppAT 驱动谷氨酰胺依赖性嘌呤生物合成和肝细胞癌的恶性进展。

Zhou Junbin, Dong Cainiao, Xu Shengqian, Wang Jun, Ye Hailin, Fan Xiaopeng, Li Shimiao, Wang Shi

SLIT2 modulates NMIIA to regulate mitophagy and suppress hepatocellular carcinoma progression.

SLIT2 调节 NMIIA 以调节线粒体自噬并抑制肝细胞癌的进展。

Qin Yong, Zhou Junbin, Li Shimiao, Liu Xiaofeng, Xu Shengqian

S100a4 promotes metastatic transformation in non-metastatic liver cancer cells through NMIIa binding: mechanistic insights.

S100a4 通过 NMIIa 结合促进非转移性肝癌细胞的转移转化:机制研究

Qin Yong, Wang Chaojun, Xu Shengqian, Zhou Junbin, Li Shimiao, Ye Hailin

Transcription factor 7 like 2 promotes metastasis in hepatocellular carcinoma via NEDD9-mediated activation of AKT/mTOR signaling pathway.

转录因子 7 样 2 通过 NEDD9 介导的 AKT/mTOR 信号通路激活促进肝细胞癌转移

Tang Linsong, Xu Shengjun, Wei Rongli, Fan Guanghan, Zhou Junbin, Wei Xuyong, Xu Xiao

Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma

建立和验证与胆固醇代谢相关的肝细胞癌预后特征

Tang, Linsong; Wei, Rongli; Chen, Ronggao; Fan, Guanghan; Zhou, Junbin; Qi, Zhetuo; Wang, Kai; Wei, Qiang; Wei, Xuyong; Xu, Xiao

Combination of Early Allograft Dysfunction and Protein Expression Patterns Predicts Outcome of Liver Transplantation From Donation After Cardiac Death

早期同种异体移植功能障碍和蛋白质表达模式的组合可预测心脏死亡后捐献肝移植的预后

Wei, Qiang; Zhou, Junbin; Wang, Kun; Zhang, Xuanyu; Chen, Junli; Lu, Di; Wei, Xuyong; Zheng, Shusen; Xu, Xiao

Coronavirus disease 2019: implications for liver transplantation

2019冠状病毒病:对肝移植的影响

Wei, Qiang; Zhou, Junbin; Shen, Tian; Zheng, Shusen; Xu, Xiao

Early allograft dysfunction after liver transplantation with donation after cardiac death donors

采用心脏死亡后捐献的供体进行肝移植后早期移植物功能障碍

Zhou, Junbin; Wei, Qiang; Zheng, Shusen; Xu, Xiao